Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Interleukin-12 in Treating Patients With Multiple Myeloma

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: November 1, 1999
Last updated: June 20, 2013
Last verified: March 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2006
  Estimated Primary Completion Date: No date given
Lacy MQ, Blood E, Kay N, et al.: Interleukin-12 treatment for plateau phase multiple myeloma: an Eastern Cooperative Oncology Group (ECOG) phase II trial (E1A96). [Abstract] Blood 100 (11 pt 1): A-1549, 2002.